Clinical Trial: A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470073) titled 'A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults' on March 09.

Brief Summary: This study is a single arm, open label, dose exploring clinical trial to evaluate the safety, efficacy, cellular metabolic dynamics, and pharmacodynamics of ct1190b cells in relapsed / refractory B-cell acute lymphoblastic leukemia.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: ALL (Acute B-Lymphoblastic Leukemia)

Intervention: BIOLOGICAL: CT1190B ...